Public Profile

APELOA

APELOA, officially known as APELOA Pharmaceutical Co., Ltd., is a prominent player in the pharmaceutical industry, headquartered in China (CN). Founded in 2001, the company has established a strong presence in major operational regions across Asia and beyond, focusing on the development and manufacturing of high-quality generic drugs and active pharmaceutical ingredients (APIs). With a commitment to innovation, APELOA offers a diverse portfolio of products, including oncology medications and cardiovascular treatments, distinguished by their rigorous quality standards and competitive pricing. The company has achieved significant milestones, including numerous certifications and partnerships that enhance its market position. Recognised for its dedication to research and development, APELOA continues to contribute to global healthcare solutions, solidifying its reputation as a trusted name in the pharmaceutical sector.

DitchCarbon Score

How does APELOA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

19

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

APELOA's score of 19 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.

12%

Let us know if this data was useful to you

APELOA's reported carbon emissions

As of 2024, APELOA has not disclosed specific carbon emissions data, including Scope 1, 2, or 3 emissions. Consequently, there are no absolute emissions figures available for analysis. The company has not set any formal reduction targets or climate pledges, indicating a potential area for improvement in their climate commitments. In the absence of detailed emissions data, APELOA's climate strategy remains unclear. However, the company operates within a global context where many organisations are increasingly prioritising sustainability and carbon reduction initiatives. It is essential for APELOA to consider establishing measurable targets and transparent reporting to align with industry standards and stakeholder expectations regarding climate action.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. APELOA's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for APELOA is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

APELOA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Aether Industries

IN
Furniture; other manufactured goods n.e.c. (36)
Updated 23 minutes ago

Otsuka Chemical Co., Ltd.

JP
Chemicals nec
Updated 6 days ago
DitchCarbon Score

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers